Results 21 to 30 of about 120,713 (70)

Computational Design of an mRNA Vaccine Targeting LRP6 for Triple-Negative Breast Cancer Therapy. [PDF]

Cancer Rep (Hoboken)
Teimoori P, Heidari M.
europepmc   +1 more source

Integrated Network Pharmacology and Machine Learning to Reveal the Mechanisms of Schisandrin A Against Triple-Negative Breast Cancer. [PDF]

J Cell Mol Med
Xu M, Zhang Y, Mei R, Xue T, Cai H, Zhou Y, Guo J.   +6 more
europepmc   +1 more source

The role of pluripotency regulators in triple-negative breast cancer immune response. [PDF]

Front Genet
López-Santana C, Mendez-Rivera F, Bernal-Estévez DA.   +2 more
europepmc   +1 more source

Spatial organization of the tumor immune microenvironment in LAR+ triple-negative breast cancer. [PDF]

Front Immunol
Lucchetti D, Di Leone A, Sabbatinelli G, Toma F, Antonio F, Cellini B, Colella F, Pazzaglia E, Parrillo C, Giacó L, Santoro A, Piermattei A, Colonna R, Franceschini G, Sgambato A.   +14 more
europepmc   +1 more source

SPDEF downregulation promotes tumor aggressiveness and poor prognosis in triple-negative breast cancer. [PDF]

Transl Cancer Res
Wei C, Liu Q, Wang H, Liu X.
europepmc   +1 more source

Polyphyllin B induces ferroptosis in triple-negative breast cancer by inactivating NRF2. [PDF]

Front Pharmacol
Deng P, Zhu S, Wu Y, Fang Z, Zhang A, Zhang D, Hu X, Zhou X.   +7 more
europepmc   +1 more source

CANT1 as a novel prognostic biomarker in triple-negative breast cancer. [PDF]

Oncol Lett
Bayram D, Çolak A, Karabulut Ş, Özsan Çelebi SN, Hafizoğlu E, Türkay DÖ, Bal Ö, Algin E, Yücel Ş, Şendur MAN, Civelek B, Uçar G.   +11 more
europepmc   +1 more source

Targeting the RXR Pathway for the Prevention of Triple-Negative Breast Cancer. [PDF]

Cancer Prev Res (Phila)
Moyer CL, Hill JL, Coleman D, Lanier A, Ma Y, Liu X, Kawedia J, Contreras A, Vuligonda V, Savage MI, Sanders ME, Mohammed A, Sei S, Brown PH, Mazumdar A.   +14 more
europepmc   +1 more source